Selected article for: "antibiotic therapy and risk factor"
Author: Di Pasquale, Marta Francesca; Sotgiu, Giovanni; Gramegna, Andrea; Radovanovic, Dejan; Terraneo, Silvia; Reyes, Luis F; Rupp, Jan; González del Castillo, Juan; Blasi, Francesco; Aliberti, Stefano; Restrepo, Marcos I
Title: Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients
  • Cord-id: ej5f4ox7
  • Document date: 2018_8_23
    • ID: ej5f4ox7
    Snippet: BACKGROUND: The correct management of immunocompromised patients with pneumonia is debated. We evaluated the prevalence, risk factors, and characteristics of immunocompromised patients coming from the community with pneumonia. METHODS: We conducted a secondary analysis of an international, multicenter study enrolling adult patients coming from the community with pneumonia and hospitalized in 222 hospitals in 54 countries worldwide. Risk factors for immunocompromise included AIDS, aplastic anemia
    Document: BACKGROUND: The correct management of immunocompromised patients with pneumonia is debated. We evaluated the prevalence, risk factors, and characteristics of immunocompromised patients coming from the community with pneumonia. METHODS: We conducted a secondary analysis of an international, multicenter study enrolling adult patients coming from the community with pneumonia and hospitalized in 222 hospitals in 54 countries worldwide. Risk factors for immunocompromise included AIDS, aplastic anemia, asplenia, hematological cancer, chemotherapy, neutropenia, biological drug use, lung transplantation, chronic steroid use, and solid tumor. RESULTS: At least 1 risk factor for immunocompromise was recorded in 18% of the 3702 patients enrolled. The prevalences of risk factors significantly differed across continents and countries, with chronic steroid use (45%), hematological cancer (25%), and chemotherapy (22%) the most common. Among immunocompromised patients, community-acquired pneumonia (CAP) pathogens were the most frequently identified, and prevalences did not differ from those in immunocompetent patients. Risk factors for immunocompromise were independently associated with neither Pseudomonas aeruginosa nor non–community-acquired bacteria. Specific risk factors were independently associated with fungal infections (odds ratio for AIDS and hematological cancer, 15.10 and 4.65, respectively; both P = .001), mycobacterial infections (AIDS; P = .006), and viral infections other than influenza (hematological cancer, 5.49; P < .001). CONCLUSIONS: Our findings could be considered by clinicians in prescribing empiric antibiotic therapy for CAP in immunocompromised patients. Patients with AIDS and hematological cancer admitted with CAP may have higher prevalences of fungi, mycobacteria, and noninfluenza viruses.

    Search related documents:
    Co phrase search for related documents
    • adjust analysis and logistic analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • adjust analysis and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • adjust analysis and logistic regression model: 1
    • admission frequent and logistic analysis: 1
    • admission frequent and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8
    • admission frequent and logistic regression model: 1, 2, 3, 4, 5
    • admission frequent and lung cancer: 1, 2
    • admission frequent and lymphocyte count: 1, 2
    • logistic analysis and long term therapy: 1
    • logistic analysis and long term treatment: 1, 2, 3
    • logistic analysis and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • logistic analysis and lung transplantation: 1, 2, 3
    • logistic analysis and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • logistic regression and long term therapy: 1, 2, 3
    • logistic regression and long term treatment: 1, 2, 3, 4, 5
    • logistic regression and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • logistic regression and lung organ transplant: 1, 2
    • logistic regression and lung transplantation: 1, 2, 3, 4, 5, 6
    • logistic regression and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25